These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10836133)

  • 1. The impact of genomics on drug discovery.
    Debouck C; Metcalf B
    Annu Rev Pharmacol Toxicol; 2000; 40():193-207. PubMed ID: 10836133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of constitutively active GPCRs in drug discovery and functional genomics.
    Chalmers DT; Behan DP
    Nat Rev Drug Discov; 2002 Aug; 1(8):599-608. PubMed ID: 12402500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors.
    Birkenbach M; Josefsen K; Yalamanchili R; Lenoir G; Kieff E
    J Virol; 1993 Apr; 67(4):2209-20. PubMed ID: 8383238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases.
    Cho CH; Nuttall ME
    Expert Opin Ther Targets; 2002 Dec; 6(6):679-89. PubMed ID: 12472380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology.
    Marchese A; George SR; Kolakowski LF; Lynch KR; O'Dowd BF
    Trends Pharmacol Sci; 1999 Sep; 20(9):370-5. PubMed ID: 10462760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular approaches to receptors as targets for drug discovery.
    Herz JM; Thomsen WJ; Yarbrough GG
    J Recept Signal Transduct Res; 1997 Sep; 17(5):671-776. PubMed ID: 9292776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts.
    Drake FH; Dodds RA; James IE; Connor JR; Debouck C; Richardson S; Lee-Rykaczewski E; Coleman L; Rieman D; Barthlow R; Hastings G; Gowen M
    J Biol Chem; 1996 May; 271(21):12511-6. PubMed ID: 8647859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin K and the design of inhibitors of cathepsin K.
    Yamashita DS; Dodds RA
    Curr Pharm Des; 2000 Jan; 6(1):1-24. PubMed ID: 10637370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization and chromosome localization of the human cathepsin K gene (CTSK).
    Rood JA; Van Horn S; Drake FH; Gowen M; Debouck C
    Genomics; 1997 Apr; 41(2):169-76. PubMed ID: 9143491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orphan G-protein-coupled receptors: the next generation of drug targets?
    Wilson S; Bergsma DJ; Chambers JK; Muir AI; Fantom KG; Ellis C; Murdock PR; Herrity NC; Stadel JM
    Br J Pharmacol; 1998 Dec; 125(7):1387-92. PubMed ID: 9884064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors.
    Wittenberger T; Schaller HC; Hellebrand S
    J Mol Biol; 2001 Mar; 307(3):799-813. PubMed ID: 11273702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to identify ligands for orphan G-protein-coupled receptors.
    Milligan G
    Biochem Soc Trans; 2002 Aug; 30(4):789-93. PubMed ID: 12196198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTS in the new millennium: the role of pharmacology and flexibility.
    Landro JA; Taylor IC; Stirtan WG; Osterman DG; Kristie J; Hunnicutt EJ; Rae PM; Sweetnam PM
    J Pharmacol Toxicol Methods; 2000; 44(1):273-89. PubMed ID: 11274895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mouse cathepsin K gene, the gene promoter, and the gene expression.
    Li YP; Chen W
    J Bone Miner Res; 1999 Apr; 14(4):487-99. PubMed ID: 10234569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone.
    Inaoka T; Bilbe G; Ishibashi O; Tezuka K; Kumegawa M; Kokubo T
    Biochem Biophys Res Commun; 1995 Jan; 206(1):89-96. PubMed ID: 7818555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference targeting cathepsin L and Z-like cysteine proteases of Onchocerca volvulus confirmed their essential function during L3 molting.
    Lustigman S; Zhang J; Liu J; Oksov Y; Hashmi S
    Mol Biochem Parasitol; 2004 Dec; 138(2):165-70. PubMed ID: 15555728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues.
    Dodds RA; Connor JR; Drake FH; Gowen M
    Arthritis Rheum; 1999 Aug; 42(8):1588-93. PubMed ID: 10446855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin P, a novel protease in mouse placenta.
    Sol-Church K; Frenck J; Troeber D; Mason RW
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):307-9. PubMed ID: 10510293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulfilling the promise: drug discovery in the post-genomic era.
    Chanda SK; Caldwell JS
    Drug Discov Today; 2003 Feb; 8(4):168-74. PubMed ID: 12581711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K.
    Moran MT; Schofield JP; Hayman AR; Shi GP; Young E; Cox TM
    Blood; 2000 Sep; 96(5):1969-78. PubMed ID: 10961902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.